Study Sheds Light on Impact of Intramural Leiomyomas on Fertility: Size Matters, Removal Offers No Benefit
USA: A recent systematic review and meta-analysis have delved into the relationship between intramural leiomyomas-commonly known as fibroids-and fertility, shedding light on implications for women's reproductive health. Published in Obstetrics & Gynecology, the study synthesized findings from numerous research studies to elucidate how these benign uterine growths impact fertility outcomes.
The study found lower fertility rates for women with intramural leiomyomas and women with more than one leiomyoma in any location. The removal of leiomyoma does not improve outcomes.
Intramural leiomyomas are non-cancerous tumors that develop within the muscular wall of the uterus. They are prevalent among women of reproductive age and can vary significantly in size and number. Concerns often arise regarding their potential interference with conception and pregnancy outcomes.
Against the above background, Elizabeth A. Pritts, Wisconsin Fertility Institute, Madison, WI, and colleagues aimed to evaluate fertility outcomes based on the size and number of intramural leiomyomas and outcomes after removal.
For this purpose, the researchers searched the online databases from 1994 to 2023. A total of 5,143 studies were identified, with the inclusion of 13 study groups. The study provided data on the size and number of leiomyomas, correlating these findings with clinical pregnancy rates and rates of ongoing pregnancies or live births.
The following were the key findings of the study:
- In data sets with maximum leiomyoma diameters of less than 6 cm for study inclusion, women with leiomyomas smaller than 3 cm had lower clinical pregnancy rates than women without leiomyomas, with an odds ratio (OR) of 0.53 and, for ongoing pregnancy or live-birth rates, an OR of 0.59.
- The ORs for clinical pregnancy rates in women with intermediately-sized leiomyomas (those between 3 cm and 6 cm) were lower than in women without leiomyomas, with an OR at 0.43 and, for ongoing pregnancy or live-birth rates, an OR at 0.38.
- In data sets without exclusion for women with larger-sized leiomyomas, clinical pregnancy rates were lower for those with leiomyomas smaller than 5 cm compared with those without leiomyomas, with an OR of 0.75.
- Women with leiomyomas larger than 5 cm showed no differences in clinical pregnancy rate compared with women without leiomyomas, with an OR of 0.71.
- Although women with a single leiomyoma in any location had no differences in outcomes, those with more than one leiomyoma had lower clinical pregnancy rates and ongoing pregnancy or live birth rates, with an OR of 0.62 and 0.57, respectively.
- The clinical pregnancy rate for women undergoing myomectomy for intramural leiomyomas was no different than those with intramural leiomyomas in situ, with an OR of 1.10.
"The findings imply that even small intramural leiomyomas are linked with lower fertility; removal does not confer benefit. Women with more than one leiomyoma in any location have lower fertility," the researchers concluded.
Reference:
Pritts TL, Ogden M, Parker W, Ratcliffe J, Pritts EA. Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis. Obstet Gynecol. 2024 Jun 27. doi: 10.1097/AOG.0000000000005661. Epub ahead of print. PMID: 38935974.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.